TY - JOUR
T1 - Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan
T2 - Importance of the Promotion of Population PK/PD Analysis
AU - Shoji, Kensuke
AU - Saito, Jumpei
AU - Nakamura, Hidefumi
AU - Matsumoto, Kazuaki
AU - Oda, Kazutaka
AU - Takesue, Yoshio
AU - Miyairi, Isao
N1 - Funding Information:
K.S. received payment for lectures from Mitsubishi Tanabe Pharma, Astellas, AbbVie GK, and G.H.N. received grants from the Japan Agency for Medical Research and Development, consulting fees from Taisho Pharmaceutical Co., Ltd., Sato Pharmaceutical Co., Ltd., Nippon Zoki Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Pfizer Japan Inc., Eli Lilly Japan K.K. and Astra Zeneca K.K., and payment for lectures from Shionogi & Co., Ltd. and Chugai Pharmaceutical Co., Ltd. K.M. received grant support from Meiji Seika Pharma Co., Ltd. and Sumitomo Pharma Co., Ltd. and payment for lectures from Meiji Seika Pharma Co., Ltd. Y.T. received grant support from Shionogi & Co., Ltd. and payment for lectures from Astellas Pharma Inc. and MSD Japan. I.M. received payment for lectures and consultations from Sanofi, Takeda Pharmaceuticals, Astellas Pharma Inc., Janssen Pharmaceuticals, Fujifilm Toyama Chemical Co., Biomelieux Japan, Abbott Japan Co. and AbbVie GK. The other authors have have no conflicts of interest to disclose. This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant no. 21K16332).
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Pharmacologic knowledge is important for pediatricians conducting feasible pharmacokinetic or pharmacodynamic (PK/PD) studies or applying effective antimicrobial therapies in children. Because of the difficulties in conducting PK/PD studies in children, antimicrobial PK/PD data in children are still limited. To fill in the lack of knowledge, promotion of population PK/PD analysis, which allows us to handle sparse sampling data from individual patients, is important because it is considered a suitable methodology to conduct PK/PD studies in children with limited blood drug concentration data for PK/PD analysis. Population PK/PD analysis is also useful in the clinical setting to provide individualized optimal dosage for each patient with various conditions. Here we summarized the current aspects of pediatric PK/PD studies of antimicrobials in Japan from clinical and research perspectives, specifically focusing on the importance of population PK/PD analysis.
AB - Pharmacologic knowledge is important for pediatricians conducting feasible pharmacokinetic or pharmacodynamic (PK/PD) studies or applying effective antimicrobial therapies in children. Because of the difficulties in conducting PK/PD studies in children, antimicrobial PK/PD data in children are still limited. To fill in the lack of knowledge, promotion of population PK/PD analysis, which allows us to handle sparse sampling data from individual patients, is important because it is considered a suitable methodology to conduct PK/PD studies in children with limited blood drug concentration data for PK/PD analysis. Population PK/PD analysis is also useful in the clinical setting to provide individualized optimal dosage for each patient with various conditions. Here we summarized the current aspects of pediatric PK/PD studies of antimicrobials in Japan from clinical and research perspectives, specifically focusing on the importance of population PK/PD analysis.
KW - pharmacodynamics
KW - pharmacokinetics
KW - population PK/PD
UR - http://www.scopus.com/inward/record.url?scp=85139572132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139572132&partnerID=8YFLogxK
U2 - 10.1097/INF.0000000000003622
DO - 10.1097/INF.0000000000003622
M3 - Review article
C2 - 35763684
AN - SCOPUS:85139572132
VL - 41
SP - E418-E423
JO - Pediatric Infectious Disease Journal
JF - Pediatric Infectious Disease Journal
SN - 0891-3668
IS - 10
ER -